References
- Hackam DG, Redelmeier DA. Translation of research evidence from animals to humans. JAMA 2006;296:1731–2.
- Ledford H. Translational research: 4 ways to fix the clinical trial. Nature 2011;477:526–8.
- Jüni P, Nartey L, Reichenbach S, et al. Risk of cardiovascular events and rofecoxib: cumulative meta-analysis. Lancet 2004;364:2021–9.
- Stolley PD. Asthma mortality. Why the United States was spared an epidemic of deaths due to asthma. Am Rev Respir Dis 1972;105:883–90.
- Schardein JL. Drugs as Teratogens 1976; CRC Press, Cleveland, Ohio; p. 49.
- Van Norman GA. Limitations of animal studies for predicting toxicity in clinical trials: is it time to rethink our current approach? JACC Basic Transl Sci 2019;4:845–54.
- Wolpert L. Review of „Animal models in the light of evolution” by Niall Shanks, Ph.D., and C. Ray Greek, M.D. Philos Ethics Humanit Med 2010;5:12.
- Mergenthaler P, Meisel A. Animal models: value and translational potency in Principles of translational science in medicine – from bench to bedside, 2nd Ed.; Academic Press 2015; p. 83–90.
- Shim J, Al-Mashhadi RH, Sørensen CB, et al. Large animal models of atherosclerosis – new tools for persistent problems in cardiovascular medicine. J Pathol 2016;238:257–66.
- Perrin S. Preclinical research: Make mouse studies work. Nature 2014;507:423–5.
- Şerban RC, Scridon A. Data linking diabetes mellitus and atrial fibrillation-how strong is the evidence? From epidemiology and pathophysiology to therapeutic implications. Can J Cardiol 2018;34:1492–502.
- Bebarta B, Luyten D, Heard K. Emergency medicine animal research: does use of randomization and blinding affect the results? Acad Emerg Med 2003;10:684–7.
- Perel P, Roberts I, Sena E, W et al. Comparison of treatment effects between animal experiments and clinical trials: systematic review. BMJ 2007;334:197.
- Hausenloy DJ, Erik Bøtker H, Condorelli G, et al. Translating cardioprotection for patient benefit: position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology. Cardiovasc Res 2013;98:7–27.
- Frank-Kamenetsky M, Grefhorst A, Anderson NN, et al. Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primates. Proc Natl Acad Sci U S A 2008;105:11915–20.
- Ferreira GS, Veening-Griffioen DH, Boon WPC, et al. A standardised framework to identify optimal animal models for efficacy assessment in drug development. PLoS One 2019;14:e0218014.